No Data
Align Technology Boosted By Improving Sentiment, Easing Comps, Margins, Earns Analyst Upgrade
Leerink Partners Upgrades Align Technology(ALGN.US) to Buy Rating, Raises Target Price to $280
Leerink Partners Upgrades Align Technology to Outperform From Market Perform, Adjusts Price Target to $280 From $235
Fluctuations are expected to continue in the early days of Trump's presidency, with Citigroup favoring Medical, Financial, and other defensive Industries.
In the market volatility and uncertainty following Trump's inauguration, defensive industries such as Medical Care and finance are favored in the model portfolio created by Citigroup strategists.
Align Technology to Announce Fourth Quarter and 2024 Results on February 5, 2025
5 MedTech Stocks That Are Poised to Beat the Market in 2025